Selank 10MG - research protocol

Quickstart Highlights

Reconstitution Summary
Selank is supplied as a sterile, lyophilized peptide intended for laboratory research. It is commonly reconstituted with bacteriostatic water prior to use in research settings.

Typical Research Concentration
The final concentration depends on the volume of bacteriostatic water added during reconstitution.

Easy Measuring Note
After reconstitution, calculate the concentration based on the total volume of diluent added. Researchers should verify concentrations before preparing experimental solutions.

Storage

• Store unreconstituted vials in a cool, dry place away from direct light.
• Refrigerate after reconstitution according to laboratory best practices.
• Avoid repeated freeze-thaw cycles.
• Do not use if the solution becomes cloudy, discolored, or contains visible particles.

Dosing & Reconstitution Guide

Supplies Needed

• Selank 10 mg vial
• Bacteriostatic Water
• Sterile syringes
• Alcohol prep swabs
• Protective laboratory equipment
• Sharps disposal container

Protocol Overview

Selank is a synthetic heptapeptide derived from tuftsin and is supplied as a lyophilized powder for laboratory research. Prior to experimental use, the peptide is reconstituted with a sterile diluent to achieve the desired research concentration.

Researchers should follow aseptic laboratory techniques, accurately calculate solution concentrations, and properly store reconstituted material to maintain integrity throughout the study.

How It Works

Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin. It has been investigated in preclinical and limited clinical research for its interactions with neurochemical pathways involved in stress response, cognition, and immune regulation. Research suggests Selank may influence:

• GABAergic signaling
• Serotonergic neurotransmission
• Dopaminergic activity
• Stress-response pathways
• Neuroplasticity
• Immune system modulation

Most published human studies originate from Russia, where Selank has been investigated as an intranasal anxiolytic. It is not approved by the U.S. Food and Drug Administration, and high-quality clinical evidence remains limited.

Potential Benefits & Side Effects

Preclinical and early clinical research has explored Selank in relation to:

• Anxiety and stress-response pathways
• Cognitive function
• Memory and learning
• Attention and focus
• Neuroprotection
• Immune modulation
• Behavioral neuroscience

These represent areas of ongoing scientific investigation and should not be interpreted as established therapeutic uses.

Safety Information

Selank has not been approved by the U.S. FDA for the diagnosis, treatment, cure, or prevention of any disease. Human safety data outside limited clinical studies remain insufficient.

Potential research considerations include:

• Unknown long-term safety profile
• Potential immunogenicity associated with peptide products
• Product contamination if aseptic technique is not followed
• Local irritation associated with research administration procedures

Researchers should follow established laboratory safety procedures and applicable regulations.